Establishment Labs Holdings Inc. reported $246M of revenue over the trailing twelve months, +39% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $246M (to Q2 2026). Net income: −$39M, trailing twelve months to Q2 2026. Free cash flow: −$42M, trailing twelve months to Q2 2026. Operating margin: −7.7%, trailing twelve months to Q2 2026.

ESTAEstablishment Labs Holdings Inc.

Healthcare

$61.70+56% 1Y

$61.70

$38.9452 weeks$95.49

ESTA as reported

Establishment Labs Holdings Inc. reported $246M of revenue over the trailing twelve months, +39% on the year before. 10 reported series are charted on this page, each one as filed.

$246M

Revenue, trailing twelve months · to Q2 2026 · +39% against the twelve months before

Net income: −$39M
Net income · −56% year on year · trailing twelve months to Q2 2026
Free cash flow: −$42M
Free cash flow · −46% year on year · trailing twelve months to Q2 2026
Operating margin: −7.7%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ESTA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$246M	+39%	Q2 2026
Net income	−$39M	−56%	Q2 2026
EPS	−$1.30	−58%	Q2 2026
Gross margin	70%	n/a	Q2 2026
Operating margin	−7.7%	n/a	Q2 2026
Net margin	−16%	n/a	Q2 2026
ROE	−300%	n/a	Q2 2026
ROA	−16%	n/a	Q2 2026
ROIC	−14%	n/a	Q2 2026
Free cash flow	−$42M	−46%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.